Catheter Precision (VTAK) Net Income (QoQ) (2017 - 2026)
Catheter Precision (VTAK) Net Income (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.26 Bn | 175.96 Bn | 6.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.92 Bn | 3.81 Bn |
| 3 | Medtronic | 108.56 Bn | 99.34 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.31 Bn | 66.86 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.27 Bn | 43.60 Bn | 1.29 Bn |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.12 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.40 Bn | 2.07 Bn |
| 10 | Catheter Precision | 583,027.05 | 183,027.05 | 390,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -356.76% |
| Dec 31, 2025 | 83.09% |
| Sep 30, 2025 | 65.86% |
| Jun 30, 2025 | -58.42% |
| Mar 31, 2025 | -62.65% |
| Dec 31, 2024 | 39.64% |
| Sep 30, 2024 | 2.37% |
| Jun 30, 2024 | -57.76% |
| Mar 31, 2024 | -299.85% |
| Dec 31, 2023 | 65.28% |
| Sep 30, 2023 | -22.27% |
| Jun 30, 2023 | 97.63% |
| Mar 31, 2023 | -713.83% |
| Dec 31, 2022 | -71.30% |
| Sep 30, 2022 | 43.62% |
| Jun 30, 2022 | -53.74% |
| Mar 31, 2022 | -936.79% |
| Dec 31, 2021 | -117.21% |
| Sep 30, 2021 | 158.68% |
| Jun 30, 2021 | -1,362.12% |